The immunofluorescence assay market has witnessed robust growth recently, with its size swelling from $3.34 billion in 2024 to an expected $3.59 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. Factors behind this impressive growth include increased disease diagnosis, a rise in research and development, an escalation in autoimmune diseases, and an upsurge in cancer diagnostics and virology research.
Predicted to grow to a cool $5.4 billion by 2029 at a CAGR of 10.7%, the immunofluorescence assay market is poised for continued expansion. The forecast period will likely see considerable growth due to a rise in personalized medicine, increased infectious disease surveillance, and an uptick in autoimmune disorders and point-of-care testing. Enhancing global health preparedness is also expected to play a part. On the horizon, the market is also set for the adoption of multiplexing assays, automation and robotics, high-content imaging, advanced fluorophores, and digital pathology integration.
Get Your Free Sample of The Global Immunofluorescence Assay Market Report Here: https://www.thebusinessresearchcompany.com/sample.aspx?id=6778&type=smp
What’s Driving The Growth of The Immunofluorescence Assay Market?
The growth of the immunofluorescence assay market is largely driven by the increasing prevalence of chronic diseases. Changing lifestyles and dietary habits, along with poor weight management practices, have led to a steep rise in chronic conditions and have even engendered cancer risk in the case of some prolonged chronic infections. This has subsequently escalated the demand for immunofluorescence assays, which are extensively used in diagnosis and drug development activities. For instance, research from the Centers for Disease Control and Prevention indicates that nearly 6 in 10 adults in the USA are affected by chronic disease, which amasses a whopping $3.8 trillion in annual healthcare costs.
What Are The Major Segments In The Immunofluorescence Assay Market
– By Type: Direct Immunofluorescence, Indirect Immunofluorescence
– By Product: Reagents, Instruments, Antibodies, Kits, Consumables and Accessories
– By Disease: Cancer, Infectious Disease, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases
– By End User: Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Hospitals And Diagnostic Centers
Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report
Which Are The Key Players Operating in The Immunofluorescence Assay Market?
Companies making a noticeable impact in the immunofluorescence assay market include Thermo Fisher Scientific Inc., Abcam plc, Bio-Rad Laboratories Inc., PerkinElmer Inc., Werfen Company, Merck KGaA, Danaher Corporation, Cell Signaling Technology Inc., Vector Laboratories Inc., and INOVA Diagnostics Inc.
What Are The Important Trends To Look For In The Immunofluorescence Assay Market?
Advancements in technology have become integral to the growth of the immunofluorescence assay market. In focus is the development of technologically innovative products that can meet specific technical demands related to new virus diagnostics like COVID-19.
Which Region Dominates The Immunofluorescence Assay Market?
North America was the largest and is expected to be the fastest-growing region in the immunofluorescence assay market, covering Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does The Immunofluorescence Assay Market Offer
The Immunofluorescence Assay Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities. The immunofluorescence assay refers to equipment and consumables that operate based on a technique that allows the visualization of specific proteins and antigens in infected cells based on their ability to react with specific antibodies.
Purchase the exclusive report now to unlock valuable market insights: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6778
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Read Related Topics:
https://goodprnews.com/vertical-lift-module-market-trends/
https://goodprnews.com/viral-inactivation-market-trends/
https://goodprnews.com/whole-exome-sequencing-market-trends/
https://goodprnews.com/steel-wire-rope-and-plastic-rope-market-trends/
https://goodprnews.com/telecom-operations-management-market-trends/
https://goodprnews.com/unmanned-surface-vehicle-usv-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
